Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 2/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3167638 | 1.00 | POLB (0.56) | POLBLTA4HHTR6ALDH1A1CHRNB4 | |
| Hydrochloric Acid SCHEMBL11373827 | 0.98 | POLB (0.54) | POLBLTA4HHTR6ALDH1A1CHRNB4 | |
| SCHEMBL18019872 | 0.95 | POLB (0.63) | POLBLTA4HALDH1A1 | |
| SCHEMBL18019867 | 0.95 | POLB (0.63) | POLBLTA4HALDH1A1 | |
| SCHEMBL20109499 | 0.95 | POLB (0.63) | POLBLTA4HALDH1A1 | |
| Hydrochloric Acid SCHEMBL7155487 | 0.94 | POLB (0.61) | POLBLTA4HALDH1A1 | |
| SCHEMBL11486260 | 0.94 | POLB (0.61) | POLBLTA4HALDH1A1 | |
| Oxalic Acid SCHEMBL1443439 | 0.91 | POLB (0.51) | POLBLTA4HHTR6ALDH1A1 | |
| SCHEMBL23255157 | 0.88 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL23255515 | 0.88 | ALDH1A1 (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| US-7265145-B2 | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7265145-B2 | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | POLB 8/4885LTA4H 3440/4885HTR6 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.